819 related articles for article (PubMed ID: 12355988)
1. [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
Panza F; Solfrizzi V; D'Introno A; Capurso C; Colacicco AM; Torres F; Altomare E; Capurso A
Recenti Prog Med; 2002 Sep; 93(9):489-97. PubMed ID: 12355988
[TBL] [Abstract][Full Text] [Related]
2. [Genetic factors and a polygenic model of Alzheimer's disease].
Rogaev EI
Genetika; 1999 Nov; 35(11):1558-71. PubMed ID: 10624576
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetics of Alzheimer's disease.
Goate AM
Geriatrics; 1997 Sep; 52 Suppl 2():S9-12. PubMed ID: 9307578
[TBL] [Abstract][Full Text] [Related]
4. Presenilin-1 polymorphism in Alzheimer's disease and vascular dementia.
Matsushita S; Arai H; Muramatsu T; Makimoto K; Nakagawa T; Sasaki H; Higuchi S
Exp Neurol; 1997 Aug; 146(2):567-9. PubMed ID: 9270069
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease and apolipoprotein E-4 allele in an Amish population.
Pericak-Vance MA; Johnson CC; Rimmler JB; Saunders AM; Robinson LC; D'Hondt EG; Jackson CE; Haines JL
Ann Neurol; 1996 Jun; 39(6):700-4. PubMed ID: 8651641
[TBL] [Abstract][Full Text] [Related]
6. APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.
Kamboh MI; Sanghera DK; Ferrell RE; DeKosky ST
Nat Genet; 1995 Aug; 10(4):486-8. PubMed ID: 7670501
[TBL] [Abstract][Full Text] [Related]
7. [Molecular genetics of Alzheimer's disease--presenilin and other genes].
Tabira T
Rinsho Shinkeigaku; 1997 Dec; 37(12):1095-6. PubMed ID: 9577654
[TBL] [Abstract][Full Text] [Related]
8. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.
Harrington CR; Louwagie J; Rossau R; Vanmechelen E; Perry RH; Perry EK; Xuereb JH; Roth M; Wischik CM
Am J Pathol; 1994 Dec; 145(6):1472-84. PubMed ID: 7992850
[TBL] [Abstract][Full Text] [Related]
9. Genetic and environmental factors in Alzheimer's disease.
Tol J; Roks G; Slooter AJ; van Duijn CM
Rev Neurol (Paris); 1999; 155 Suppl 4():S10-6. PubMed ID: 10637933
[TBL] [Abstract][Full Text] [Related]
10. No association between the very low density lipoprotein receptor gene and late-onset Alzheimer's disease nor interaction with the apolipoprotein E gene in population-based and clinic samples.
Fallin D; Gauntlett AC; Scibelli P; Cai X; Duara R; Gold M; Crawford F; Mullan M
Genet Epidemiol; 1997; 14(3):299-305. PubMed ID: 9181358
[TBL] [Abstract][Full Text] [Related]
11. Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer's Disease but is not causative.
Bennett C; Crawford F; Osborne A; Diaz P; Hoyne J; Lopez R; Roques P; Duara R; Rossor M; Mullan M
Am J Med Genet; 1995 Feb; 60(1):1-6. PubMed ID: 7485228
[TBL] [Abstract][Full Text] [Related]
12. LDL receptor-related protein (LRP) in Alzheimer's disease: towards a unified theory of pathogenesis.
Van Uden E; Kang DE; Koo EH; Masliah E
Microsc Res Tech; 2000 Aug; 50(4):268-72. PubMed ID: 10936878
[TBL] [Abstract][Full Text] [Related]
13. The Glu318Gly mutation of the presenilin-1 gene does not necessarily cause Alzheimer's disease.
Mattila KM; Forsell C; Pirttilä T; Rinne JO; Lehtimäki T; Röyttä M; Lilius L; Eerola A; St George-Hyslop PH; Frey H; Lannfelt L
Ann Neurol; 1998 Dec; 44(6):965-7. PubMed ID: 9851443
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease.
Tilley L; Morgan K; Grainger J; Marsters P; Morgan L; Lowe J; Xuereb J; Wischik C; Harrington C; Kalsheker N
Eur J Hum Genet; 1999 Sep; 7(6):659-63. PubMed ID: 10482954
[TBL] [Abstract][Full Text] [Related]
15. Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases.
Egensperger R; Kösel S; Schnopp NM; Mehraein P; Graeber MB
Neuropathol Appl Neurobiol; 1997 Aug; 23(4):315-21. PubMed ID: 9292870
[TBL] [Abstract][Full Text] [Related]
16. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease.
Okuizumi K; Onodera O; Namba Y; Ikeda K; Yamamoto T; Seki K; Ueki A; Nanko S; Tanaka H; Takahashi H; Oyanagi K; Mizusawa H; Kanazawa I; Tsuji S
Nat Genet; 1995 Oct; 11(2):207-9. PubMed ID: 7550352
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E in the genetics and epidemiology of Alzheimer's disease.
Hardy J
Am J Med Genet; 1995 Oct; 60(5):456-60. PubMed ID: 8546162
[TBL] [Abstract][Full Text] [Related]
18. E280A PS-1 mutation causes Alzheimer's disease but age of onset is not modified by ApoE alleles.
Lendon CL; Martinez A; Behrens IM; Kosik KS; Madrigal L; Norton J; Neuman R; Myers A; Busfield F; Wragg M; Arcos M; Arango Viana JC; Ossa J; Ruiz A; Goate AM; Lopera F
Hum Mutat; 1997; 10(3):186-95. PubMed ID: 9298817
[TBL] [Abstract][Full Text] [Related]
19. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.
Goate A; Chartier-Harlin MC; Mullan M; Brown J; Crawford F; Fidani L; Giuffra L; Haynes A; Irving N; James L
Nature; 1991 Feb; 349(6311):704-6. PubMed ID: 1671712
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E: depressive illness, depressive symptoms, and Alzheimer's disease.
Holmes C; Russ C; Kirov G; Aitchison KJ; Powell JF; Collier DA; Lovestone S
Biol Psychiatry; 1998 Feb; 43(3):159-64. PubMed ID: 9494696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]